| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |